Search
News & Events
Medical AssessmentsPeople with type 1 diabetes require the completion of a Medical Assessment form for activities such as driving, skipper tickets and scuba-diving etc.
News & Events
Research Boost for Diabetes Team at Princess Margaret HospitalAfter an intensely competitive process, the research team at Princess Margaret Hospital were awarded $5.2million from a joint JDRF/NHMRC research grant.
News & Events
Major focus for children's diabetes research in WAResearch into childhood diabetes in Perth has been given a major boost with the launch of the WA Children's Diabetes Research and Education Centre for Research Excellence (CRE) on the eve of World Diabetes Day.
The Rio Tinto Children’s Diabetes Centre acknowledges the importance of those living with type 1 diabetes (T1D), those that care for them and the type 1 diabetes community (T1D community) in sharing your lived-experience.
For app support, please email diabetes.research@health.wa.gov.au
Two new resources have been created for patients — Know the Numbers and Your HbA1c Chart.
Research
Socioeconomic representativeness of Australian, Canadian and British cohorts from the paediatric diabetes AdDIT study: comparisons to regional and national dataGiven limited data regarding the involvement of disadvantaged groups in paediatric diabetes clinical trials, this study aimed to evaluate the socioeconomic representativeness of participants recruited into a multinational clinical trial in relation to regional and national type 1 diabetes reference populations.
Research
Feasibility and acceptability of implementing an evidence-based ESCALATION system for paediatric clinical deteriorationThe ESCALATION system is a novel paediatric Early Warning System that incorporates family involvement and sepsis recognition. This study aimed to assess the feasibility and iteratively refine the ESCALATION system in a variety of hospital settings in preparation for full-service implementation.
Research
Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: Advantages, limitations, and comparisons with laboratory-based testingType 1 diabetes is well-recognised as a continuum heralded by the development of islet autoantibodies, progression to islet autoimmunity causing beta cell destruction, culminating in insulin deficiency and clinical disease. Abnormalities of glucose homeostasis are known to exist well before the onset of typical symptoms.
Research
An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 DiabetesTo assess relationships between continuous glucose monitoring (CGM) time in range (TIR), 70-180 mg/dL, time below range (TBR), <70 mg/dL, time above range (TAR), >180 mg/dL, and glucose coefficient of variation (CV) in relation to currently recommended clinical CGM targets for older people, which recommend reduced TIR and TBR targets relative to the general type 1 diabetes population.